Literature DB >> 17108278

Yersinia enterocolitica isolates of differing biotypes from humans and animals are adherent, invasive and persist in macrophages, but differ in cytokine secretion profiles in vitro.

Alan McNally1, Tracey Dalton2, Roberto M La Ragione1, Kenneth Stapleton1, Georgina Manning1, Diane G Newell1.   

Abstract

Previous epidemiological studies have demonstrated a potential link between the serotypes of Yersinia enterocolitica recovered from cattle, sheep and pigs and those isolated from human disease cases. Further studies utilizing amplified fragment length polymorphisms have shown a relationship at the genetic level between strains of biotypes 3 and 4 from humans and livestock, and also suggested that some biotype 1A isolates, classically defined as non-pathogenic, are closely related to biotype 3 and 4 isolates. This study sought to understand further the pathogenic potential of Y. enterocolitica isolates from livestock in Great Britain. A range of surrogate in vitro models, such as invasion of epithelial tissue cultures, survival in cultured macrophages and cytokine secretion response, was employed to assess the pathogenicity of 88 strains. The results suggested that all isolates examined were capable of adhering to and invading epithelial cells and of surviving within macrophages. However, the inflammatory response of the infected macrophages differed with the infecting Y. enterocolitica subtype, with the response to pathogenic biotype 3 and 4 isolates different to that observed with biotype 1A isolates, and with the biotype 3 O : 5,27 isolates recovered exclusively from animals. Infections of porcine tissue also suggested the possibility of host-tissue tropism within Y. enterocolitica subtypes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17108278     DOI: 10.1099/jmm.0.46726-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  12 in total

1.  Yersinia enterocolitica biotype 1A: a possible new trigger of reactive arthritis.

Authors:  Riitta Tuompo; Timo Hannu; Elisa Huovinen; Leila Sihvonen; Anja Siitonen; Marjatta Leirisalo-Repo
Journal:  Rheumatol Int       Date:  2017-09-16       Impact factor: 2.631

2.  Human and animal isolates of Yersinia enterocolitica show significant serotype-specific colonization and host-specific immune defense properties.

Authors:  Julia Schaake; Malte Kronshage; Frank Uliczka; Manfred Rohde; Tobias Knuuti; Eckhard Strauch; Angelika Fruth; Melissa Wos-Oxley; Petra Dersch
Journal:  Infect Immun       Date:  2013-08-19       Impact factor: 3.441

3.  Yersinia enterocolitica and Y. enterocolitica-like species in clinical stool specimens of humans: identification and prevalence of bio/serotypes in Finland.

Authors:  L M Sihvonen; K Haukka; M Kuusi; M J Virtanen; A Siitonen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-02-14       Impact factor: 3.267

4.  Genetic relationships between clinical and non-clinical strains of Yersinia enterocolitica biovar 1A as revealed by multilocus enzyme electrophoresis and multilocus restriction typing.

Authors:  Sarita Mallik; Jugsharan S Virdi
Journal:  BMC Microbiol       Date:  2010-05-28       Impact factor: 3.605

5.  The use of the HRM method for identifying possible mutations in the ymoA gene region and evaluating their influence on the enterotoxic properties of Y. enterocolitica strains.

Authors:  Agata Bancerz-Kisiel; Karolina Lipczyńska; Anna Szczerba-Turek; Eugenia Gospodarek; Aleksandra Platt-Samoraj; Wojciech Szweda
Journal:  BMC Vet Res       Date:  2014-09-19       Impact factor: 2.741

6.  Comparative genome analysis identifies few traits unique to the Escherichia coli ST131 H30Rx clade and extensive mosaicism at the capsule locus.

Authors:  Abdulaziz Alqasim; Fleming Scheutz; Zhiyong Zong; Alan McNally
Journal:  BMC Genomics       Date:  2014-09-30       Impact factor: 3.969

7.  Comparison of Growth and the Cytokines Induced by Pathogenic Yersinia enterocolitica Bio-Serotypes 3/O: 3 and 2/O: 9.

Authors:  Haoshu Yang; Wenpeng Gu; Haiyan Qiu; Guixiang Sun; Junrong Liang; Kewei Li; Yuchun Xiao; Ran Duan; Huaiqi Jing; Xin Wang
Journal:  Front Cell Infect Microbiol       Date:  2017-05-01       Impact factor: 5.293

8.  Melatonin suppresses cisplatin-induced nephrotoxicity via activation of Nrf-2/HO-1 pathway.

Authors:  Ulkan Kilic; Ertugrul Kilic; Zeynep Tuzcu; Mehmet Tuzcu; Ibrahim H Ozercan; Okkes Yilmaz; Fikrettin Sahin; Kazim Sahin
Journal:  Nutr Metab (Lond)       Date:  2013-01-12       Impact factor: 4.169

9.  Clinical isolates of Yersinia enterocolitica biotype 1A represent two phylogenetic lineages with differing pathogenicity-related properties.

Authors:  Leila M Sihvonen; Kaisa Jalkanen; Elisa Huovinen; Susanna Toivonen; Jukka Corander; Markku Kuusi; Mikael Skurnik; Anja Siitonen; Kaisa Haukka
Journal:  BMC Microbiol       Date:  2012-09-17       Impact factor: 3.605

Review 10.  The Most Important Virulence Markers of Yersinia enterocolitica and Their Role during Infection.

Authors:  Agata Bancerz-Kisiel; Marta Pieczywek; Piotr Łada; Wojciech Szweda
Journal:  Genes (Basel)       Date:  2018-05-03       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.